HMDB0000039 | Butyric acid | 107-92-6 | | C4H8O2 | 88.1051 88.0524295 | Not Available |
HMDB0000097 | Choline | 62-49-7 | | C5H14NO | 104.1708 104.107539075 | Not Available |
HMDB0000169 | D-Mannose | 3458-28-4 | | C6H12O6 | 180.1559 180.063388116 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235 ]
|
HMDB0000220 | Palmitic acid | 57-10-3 | | C16H32O2 | 256.4241 256.240230268 | Not Available |
HMDB0000806 | Myristic acid | 544-63-8 | | C14H28O2 | 228.3709 228.20893014 | Not Available |
HMDB0000826 | Pentadecanoic acid | 1002-84-2 | | C15H30O2 | 242.3975 242.224580204 | Not Available |
HMDB0000827 | Stearic acid | 57-11-4 | | C18H36O2 | 284.4772 284.271530396 | Not Available |
HMDB0000895 | Acetylcholine | 51-84-3 | | C7H16NO2 | 146.2074 146.118103761 | Not Available |
HMDB0000910 | Tridecanoic acid | 638-53-9 | | C13H26O2 | 214.3443 214.193280076 | Not Available |
HMDB0001043 | Arachidonic acid | 506-32-1 | | C20H32O2 | 304.4669 304.240230268 | Not Available |
HMDB0001897 | Substance P | 33507-63-0 | | C63H98N18O13S | 1347.63 1346.728146002 | - Lockridge O: Substance P hydrolysis by human serum cholinesterase. J Neurochem. 1982 Jul;39(1):106-10. [PubMed:6177830 ]
|
HMDB0002111 | Water | 7732-18-5 | | H2O | 18.0153 18.010564686 | Not Available |
HMDB0002212 | Arachidic acid | 506-30-9 | | C20H40O2 | 312.5304 312.302830524 | Not Available |
HMDB0002259 | Heptadecanoic acid | 506-12-7 | | C17H34O2 | 270.4507 270.255880332 | Not Available |
HMDB0005041 | Donepezil | 120014-06-4 | | C24H29NO3 | 379.492 379.214743799 | Not Available |
HMDB0006497 | Heptadecanoyl CoA | 3546-17-6 | | C38H68N7O17P3S | 1019.97 1019.360524011 | Not Available |
HMDB0013930 | R-95913 | | | C18H18FNO2S | 331.404 331.10422772 | - Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0014324 | Ramipril | 87333-19-5 | | C23H32N2O5 | 416.5106 416.231122144 | - Shah GB, Sharma S, Mehta AA, Goyal RK: Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol. 2000 Aug;36(2):169-75. [PubMed:10942157 ]
|
HMDB0014329 | Pentagastrin | 5534-95-2 | | C37H49N7O9S | 767.891 767.331246891 | - Chernysheva SV, Iaremko EE: [Cholinergic and hormonal correlations in the regulation of the secretory function of the small intestine]. Fiziol Zh SSSR Im I M Sechenova. 1983 Jun;69(6):827-31. [PubMed:6873393 ]
|
HMDB0014347 | Succinylcholine | 306-40-1 | | C14H30N2O4 | 290.399 290.220557458 | - Ostergaard D, Engbaek J, Viby-Mogensen J: Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp. 1989 Sep-Oct;4(5):351-68. [PubMed:2682131 ]
|
HMDB0014502 | Mefloquine | 53230-10-7 | | C17H16F6N2O | 378.3122 378.116682374 | - Lim LY, Go ML: The anticholinesterase activity of mefloquine. Clin Exp Pharmacol Physiol. 1985 Sep-Oct;12(5):527-31. [PubMed:3878759 ]
- Zhou C, Xiao C, McArdle JJ, Ye JH: Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase. J Pharmacol Exp Ther. 2006 Jun;317(3):1155-60. Epub 2006 Feb 24. [PubMed:16501066 ]
- McArdle JJ, Sellin LC, Coakley KM, Potian JG, Quinones-Lopez MC, Rosenfeld CA, Sultatos LG, Hognason K: Mefloquine inhibits cholinesterases at the mouse neuromuscular junction. Neuropharmacology. 2005 Dec;49(8):1132-9. Epub 2005 Aug 2. [PubMed:16081111 ]
|
HMDB0014526 | Tacrine | 321-64-2 | | C13H14N2 | 198.2637 198.115698458 | - Wang H, Tang XC: Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Zhongguo Yao Li Xue Bao. 1998 Jan;19(1):27-30. [PubMed:10375753 ]
- Krustev AD, Argirova MD, Getova DP, Turiiski VI, Prissadova NA: Calcium-independent tacrine-induced relaxation of rat gastric corpus smooth muscles. Can J Physiol Pharmacol. 2006 Nov;84(11):1133-8. [PubMed:17218977 ]
- Marco JL, Carreiras MC: Recent developments in the synthesis of acetylcholinesterase inhibitors. Mini Rev Med Chem. 2003 Sep;3(6):518-24. [PubMed:12871155 ]
- Ahmed M, Rocha JB, Correa M, Mazzanti CM, Zanin RF, Morsch AL, Morsch VM, Schetinger MR: Inhibition of two different cholinesterases by tacrine. Chem Biol Interact. 2006 Aug 25;162(2):165-71. Epub 2006 Jun 17. [PubMed:16860785 ]
|
HMDB0014535 | Sulpiride | 15676-16-1 | | C15H23N3O4S | 341.426 341.140926929 | - Vacca C, Maione S, Tozzi A, Marmo E: Benzamides and cholinesterases. Res Commun Chem Pathol Pharmacol. 1987 Feb;55(2):193-201. [PubMed:3823608 ]
- Dross K: [The relevance of anticholinesterase properties to toxicity and neuromuscular effects of sulpiride (author's transl)]. Arzneimittelforschung. 1977 Feb;27(2):404-6. [PubMed:577162 ]
|
HMDB0014536 | Ethopropazine | 1094-08-2 | | C19H24N2S | 312.472 312.166019468 | - Reiner E, Bosak A, Simeon-Rudolf V: Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase. Arh Hig Rada Toksikol. 2004 Apr;55(1):1-4. [PubMed:15137175 ]
- Sinko G, Kovarik Z, Reiner E, Simeon-Rudolf V, Stojan J: Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers. Biochimie. 2011 Oct;93(10):1797-807. doi: 10.1016/j.biochi.2011.06.023. Epub 2011 Jun 29. [PubMed:21740955 ]
|
HMDB0014592 | Dipivefrin | 52365-63-6 | | C19H29NO5 | 351.4373 351.204573043 | - Nakamura M, Shirasawa E, Hikida M: Characterization of esterases involved in the hydrolysis of dipivefrin hydrochloride. Ophthalmic Res. 1993;25(1):46-51. [PubMed:8446367 ]
|